Emcure Pharmaceuticals Limited Share Price

Stocks

EMCURE

INE168P01015

Pharmaceuticals

End-of-day quote NSE India S.E. 17/07/2026 5-day change 1st Jan Change
1,783.20 INR -1.08% Intraday chart for Emcure Pharmaceuticals Limited -1.45% +30.69%

Valuation: Emcure Pharmaceuticals Limited

Market Cap 338B 3.51B 3.07B 2.83B 2.61B 4.92B 5.03B 33.87B 13.31B 166B 13.19B 12.9B 570B P/E 2026
32.7x
P/E 2027 * 29.3x
Enterprise Value 345B 3.58B 3.13B 2.89B 2.66B 5.02B 5.13B 34.55B 13.57B 169B 13.45B 13.15B 582B EV / Sales 2026
3.33x
EV / Sales 2027 * 3.28x
Free-Float
18.3%
Yield 2026
0.23%
Yield 2027 * 0.21%
1 day-1.08%
1 week-1.45%
Current month-2.88%
1 month+2.78%
3 months+8.80%
6 months+14.42%
Current year+30.69%
1 week 1,751
Extreme 1751
1,840
1 month 1,725.7
Extreme 1725.7
1,944
Current year 1,381
Extreme 1381
1,944
1 year 1,260
Extreme 1260
1,944
3 years 889
Extreme 889
1,944
5 years 889
Extreme 889
1,944
10 years 889
Extreme 889
1,944
Manager TitleAgeSince
Chief Executive Officer 75 15/04/1981
Director of Finance/CFO - 30/09/2003
Compliance Officer - 03/02/2026
Director TitleAgeSince
Chairman 69 -
Director/Board Member 72 22/07/2001
Director/Board Member 75 15/04/1981
Change 5-day change 1-year change 3-year change Capi.($)
-1.08%-1.45%+30.88% - 3.55B
+0.85%-3.11%+49.29%+162.34% 1,043B
+1.23%-2.34%+53.56%+58.28% 602B
+0.04%+1.83%+33.53%+87.11% 449B
+0.78%-0.39%+30.44%+23.23% 327B
+1.41%+0.56%+31.41%+47.13% 279B
-0.27%-5.69%+20.68%+21.99% 264B
-1.42%+0.73%+22.50%+61.06% 201B
-1.48%-0.42%+22.24%+73.96% 169B
-0.36%+3.30%+1.79%-31.03% 143B
Average -0.08%-0.67%+29.63%+56.01% 348.06B
Weighted average by Cap. +0.15%-1.81%+37.79%+83.50%

Financials

2026 2027 *
Net sales 91.56B 951M 831M 767M 707M 1.33B 1.36B 9.17B 3.6B 44.83B 3.57B 3.49B 154B 104B 1.08B 948M 875M 806M 1.52B 1.55B 10.46B 4.11B 51.12B 4.07B 3.98B 176B
Net income 9.81B 102M 89.07M 82.23M 75.76M 143M 146M 983M 386M 4.8B 383M 374M 16.55B 11.5B 119M 104M 96.36M 88.77M 167M 171M 1.15B 452M 5.63B 448M 439M 19.4B
Net Debt 6.75B 70.1M 61.28M 56.57M 52.12M 98.27M 100M 676M 266M 3.3B 263M 257M 11.39B 4.56B 47.41M 41.44M 38.26M 35.25M 66.46M 67.93M 457M 180M 2.23B 178M 174M 7.7B
Logo Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited is an India-based pharmaceutical company, which is engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several major therapeutic areas. It offers a range of products and services under formulations, biologics and Active Pharmaceutical Ingredient (APIs). It operates across a wide scope of areas, including Gynecology, Cardiovascular, HIV Antivirals, VMN (Vitamins, Minerals & Nutrients), Pain/Analgesics, Nephrology, Oncology, Anti-Infective, Respiratory, CNS. Its brands include Orofer XT and Pause (Gynecological), Proxym (pain), Tenectase (CNS), Vylda (diabetology), Vitanova (VMN). Its API products include S-Amlodipine, Ferric Carboxymaltose, Ferrous Ascorbate and Eribulin. Its biologics business offers various products, including Elaxim (Tenecteplase), Vintor (Erythropoietin), TENECTASE (Tenecteplase). It has developed two platforms: Mammalian and Microbial.
Employees
6,731
Date Price Change Volume
17/07/26 ₹1,783.20 -1.08% 239,836
16/07/26 ₹1,802.70 +0.69% 120,724
15/07/26 ₹1,790.30 -1.09% 95,679
14/07/26 ₹1,810.10 +0.94% 138,088
13/07/26 ₹1,793.30 -1.16% 87,267
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1,783.20INR
Average target price
1,913.50INR
Spread / Average Target
+7.31%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EMCURE Stock